Personalized mRNA tumor vaccine (Stemirna Therapeutics)

编码新生抗原的mRNA个性化肿瘤疫苗

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePersonalized mRNA tumor vaccine (Stemirna Therapeutics)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionGene transferenceImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A